Hepatocellular carcinoma response to transarterial chemo-embolization is traditionally assessed by qualitative interpretation of imaging features and enhancement dynamics. However, quantitative parameters derived by fitting a dual-input single-compartment model on dynamic contrast-enhanced-MRI data show promise, as they may help discriminate non-viable from viable tumors after treatment. Peak enhancement ratio significantly decreased after transarterial chemo-embolization in tumors with complete response (i.e. non-viable tumor group). This pilot study suggests that quantitative dynamic contrast-enhanced-MRI parameters may be used to assess treatment response.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords